PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SURG vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between SURG and SPY is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

SURG vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SurgePays, Inc. (SURG) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-50.00%
5.95%
SURG
SPY

Key characteristics

Sharpe Ratio

SURG:

-0.83

SPY:

2.05

Sortino Ratio

SURG:

-1.45

SPY:

2.73

Omega Ratio

SURG:

0.83

SPY:

1.38

Calmar Ratio

SURG:

-0.76

SPY:

3.07

Martin Ratio

SURG:

-1.16

SPY:

13.22

Ulcer Index

SURG:

64.91%

SPY:

1.95%

Daily Std Dev

SURG:

90.90%

SPY:

12.57%

Max Drawdown

SURG:

-100.00%

SPY:

-55.19%

Current Drawdown

SURG:

-100.00%

SPY:

-2.69%

Returns By Period

In the year-to-date period, SURG achieves a -1.69% return, which is significantly lower than SPY's 0.58% return. Over the past 10 years, SURG has underperformed SPY with an annualized return of -19.29%, while SPY has yielded a comparatively higher 13.26% annualized return.


SURG

YTD

-1.69%

1M

-2.78%

6M

-41.47%

1Y

-76.06%

5Y*

-38.66%

10Y*

-19.29%

SPY

YTD

0.58%

1M

-1.88%

6M

6.61%

1Y

25.28%

5Y*

14.36%

10Y*

13.26%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SURG vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SURG
The Risk-Adjusted Performance Rank of SURG is 1010
Overall Rank
The Sharpe Ratio Rank of SURG is 99
Sharpe Ratio Rank
The Sortino Ratio Rank of SURG is 66
Sortino Ratio Rank
The Omega Ratio Rank of SURG is 88
Omega Ratio Rank
The Calmar Ratio Rank of SURG is 66
Calmar Ratio Rank
The Martin Ratio Rank of SURG is 1919
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 8282
Overall Rank
The Sharpe Ratio Rank of SPY is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 8080
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 8282
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 8282
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8484
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SURG vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for SurgePays, Inc. (SURG) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SURG, currently valued at -0.83, compared to the broader market-4.00-2.000.002.00-0.832.05
The chart of Sortino ratio for SURG, currently valued at -1.45, compared to the broader market-4.00-2.000.002.004.00-1.452.73
The chart of Omega ratio for SURG, currently valued at 0.83, compared to the broader market0.501.001.502.000.831.38
The chart of Calmar ratio for SURG, currently valued at -0.76, compared to the broader market0.002.004.006.00-0.763.07
The chart of Martin ratio for SURG, currently valued at -1.16, compared to the broader market-10.000.0010.0020.00-1.1613.22
SURG
SPY

The current SURG Sharpe Ratio is -0.83, which is lower than the SPY Sharpe Ratio of 2.05. The chart below compares the historical Sharpe Ratios of SURG and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.83
2.05
SURG
SPY

Dividends

SURG vs. SPY - Dividend Comparison

SURG has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.20%.


TTM20242023202220212020201920182017201620152014
SURG
SurgePays, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.20%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

SURG vs. SPY - Drawdown Comparison

The maximum SURG drawdown since its inception was -100.00%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for SURG and SPY. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-100.00%
-2.69%
SURG
SPY

Volatility

SURG vs. SPY - Volatility Comparison

SurgePays, Inc. (SURG) has a higher volatility of 11.45% compared to SPDR S&P 500 ETF (SPY) at 4.49%. This indicates that SURG's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
11.45%
4.49%
SURG
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab